Home » Topics » BioWorld Science

BioWorld Science
RSS

Potent antiobesity effect seen with ZP-8396 in combination with semaglutide

Nov. 5, 2021

Computational prodding of evolutionary history gives clues to gene variants

Nov. 4, 2021

Burning Rock to support testing of Impact's ATR inhibitor IMP-9064

Nov. 4, 2021

SLC6A14 polymorphism tied to cystic fibrosis severity

Nov. 4, 2021

Defence Therapeutics' AccuVAC-PT001 COVID-19 vaccine completes toxicology studies in rabbits

Nov. 4, 2021

Versameb's VMB-100 shows promise for stress urinary incontinence in animal model

Nov. 4, 2021

RAPT Therapeutics patents USP7 inhibitors

Nov. 4, 2021

Discovery of novel IDO1 inhibitors for the treatment of cancer

Nov. 4, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical describes HBV antivirals

Nov. 4, 2021

Chinese researchers present new glucose-lowering agents

Nov. 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...